Suzhou Basecare Medical Management
Management criteria checks 3/4
Suzhou Basecare Medical's CEO is Bo Liang, appointed in Dec 2010, has a tenure of 13.42 years. total yearly compensation is CN¥3.04M, comprised of 91% salary and 9% bonuses, including company stock and options. directly owns 20.77% of the company’s shares, worth HK$117.64M. The average tenure of the management team and the board of directors is 6.3 years and 3.3 years respectively.
Key information
Bo Liang
Chief executive officer
CN¥3.0m
Total compensation
| CEO salary percentage | 91.0% |
| CEO tenure | 13.4yrs |
| CEO ownership | 20.8% |
| Management average tenure | 6.3yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch
Mar 22
Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?
Aug 01Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop
May 26Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?
Jul 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥192m |
| Sep 30 2023 | n/a | n/a | -CN¥176m |
| Jun 30 2023 | n/a | n/a | -CN¥160m |
| Mar 31 2023 | n/a | n/a | -CN¥146m |
| Dec 31 2022 | CN¥3m | CN¥3m | -CN¥132m |
| Sep 30 2022 | n/a | n/a | -CN¥133m |
| Jun 30 2022 | n/a | n/a | -CN¥135m |
| Mar 31 2022 | n/a | n/a | -CN¥139m |
| Dec 31 2021 | CN¥4m | CN¥3m | -CN¥144m |
| Sep 30 2021 | n/a | n/a | -CN¥119m |
| Jun 30 2021 | n/a | n/a | -CN¥106m |
| Mar 31 2021 | n/a | n/a | -CN¥490m |
| Dec 31 2020 | CN¥8m | CN¥1m | -CN¥874m |
| Sep 30 2020 | n/a | n/a | -CN¥1b |
| Jun 30 2020 | n/a | n/a | -CN¥1b |
| Mar 31 2020 | n/a | n/a | -CN¥822m |
| Dec 31 2019 | CN¥732k | CN¥602k | -CN¥528m |
Compensation vs Market: Bo's total compensation ($USD420.24K) is above average for companies of similar size in the Hong Kong market ($USD233.89K).
Compensation vs Earnings: Bo's compensation has been consistent with company performance over the past year.
CEO
Bo Liang (42 yo)
13.4yrs
Tenure
CN¥3,043,000
Compensation
Dr. Bo Liang serves as Executive Director and General Manager at Suzhou Basecare Medical Corporation Limited since December 14, 2010 and serves as its Chairman of the Board since December 14, 2015. Dr. Lia...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 13.4yrs | CN¥3.04m | 20.77% CN¥ 117.6m | |
| Chief Operating Officer | 6.9yrs | CN¥306.00k | no data | |
| CTO & Executive Director | 10yrs | CN¥886.00k | no data | |
| Chief Quality Officer & Executive Director | 5.7yrs | CN¥569.00k | no data | |
| CFO & Joint Company Secretary | 1.5yrs | no data | no data | |
| Joint Company Secretary | 1.8yrs | no data | no data |
6.3yrs
Average Tenure
41.5yo
Average Age
Experienced Management: 2170's management team is seasoned and experienced (6.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | 13.4yrs | CN¥3.04m | 20.77% CN¥ 117.6m | |
| CTO & Executive Director | 7.9yrs | CN¥886.00k | no data | |
| Chief Quality Officer & Executive Director | 2.1yrs | CN¥569.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥172.00k | no data | |
| Non-Executive Director | 5.5yrs | no data | no data | |
| Non-Executive Director | 7.7yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-executive Director | less than a year | no data | no data | |
| Non-executive Director | less than a year | no data | no data |
3.3yrs
Average Tenure
42yo
Average Age
Experienced Board: 2170's board of directors are considered experienced (3.3 years average tenure).